Evidence map›Paper›PMID 23923082›Full record

ArticleInternational journal of clinical and experimental pathology2013

Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.

Eva V George, John Pharm, Courtney Houston, Semar Al-Quran, Grey Brian, Huijia Dong, Wang Hai, Westley Reeves, Li-Jun Yang

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Breast implant-associated anaplastic large cell lymphoma: a review.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2019
    Review
  13. Article
  14. Breast Implant-Associated Lymphoma.Deutsches Arzteblatt international · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.Annals of oncology : official journal of the European Society for Medical Oncology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Eva V GeorgeDepartment of Pathology, Immunology, Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32607, USA.
John Pharm
Courtney Houston
Semar Al-Quran
Grey Brian
Huijia Dong
Wang Hai
Westley Reeves
Li-Jun Yang
University of Florida · US

Funding

Pathogenesis on Autoantibodies in Pristane-Induced LupusR01AR044731 · NIAMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI REEVES, WESTLEY H · 1997 to 2021
$6.6M
NIAMS NIH HHS R01 AR044731
6 · The paper itself

Abstract

Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is a recently recognized clinical entity, with only 39 well-documented cases reported worldwide, including 3 fatalities. Because of its rarity, the clinical and pathologic features of this malignancy have yet to be fully defined. Moreover, the pathogenesis of ALCL in association with textured silicone gel breast implants is poorly understood. Here we report a case of BIA-ALCL arising in a 67-year-old woman with a mastectomy due to breast cancer followed by implantation of textured silicone gel breast prosthesis. The patient presented with breast enlargement and tenderness 8 years following reconstructive surgery. MRI revealed a fluid collection surrounding the affected breast implant. Pathologic examination confirmed the presence of malignant ALCL T cells that were CD30+, CD8+, CD15+, HLA-DR+, CD25+ ALK- and p53. A diagnosis of indolent BIA-ALCL was made since tumor cells were not found outside of the capsule. Interestingly, an extensive mixed lymphocytic infiltrate and ectopic lymphoid tissue (lymphoid neogenesis) adjacent to the fibrous implant capsule were present. The patient was treated with capsulectomy and implantation of new breast prostheses. Six months later, the patient was found to have BIA-ALCL involvement of an axillary lymph node with cytogenetic evolution of the tumor. To our knowledge, this is the sixth reported case of aggressive BIA-ALCL. Unique features of this case include the association with lymphoid neogenesis and the in vivo cytogenetic progression of the tumor. This case provides insight into the potential role of chronic inflammation and genetic instability in the pathogenesis of BIA-ALCL.

Indexed as

AgedAnaplastic Lymphoma KinaseBreast ImplantsBreast NeoplasmsCarcinoma, Ductal, BreastFemaleHumansLymphoma, Large-Cell, AnaplasticNeoplasms, Second PrimaryReceptor Protein-Tyrosine KinasesALK protein, humanAnaplastic Lymphoma KinaseReceptor Protein-Tyrosine KinasesALK-negativeAnaplastic large cell lymphoma (ALCL)breast implantectopic lymphoid aggregatespathogenesis

Identifiers

PMID23923082
PMCPMC3726980
OpenAlexW1492971972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.